COVID‐19 pandemic and management of GIMEMA clinical trials: changes and challenges Redazione 9 Luglio 2020 ...
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients Redazione 9 Luglio 2020 ...
Philadelphia-Like Acute Lymphoblastic Leukemia Is Associated With Minimal Residual Disease Persistence And Poor Outcome. First Report Of The Minimal Residual Disease-Oriented GIMEMA LAL1913 Redazione 9 Luglio 2020 ...
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study Redazione 2 Luglio 2020 ...
Graft‐versus‐host‐disease does not help acute lymphoblastic leukaemia patients with measurable residual disease Redazione 2 Luglio 2020 ...
Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia Redazione 2 Luglio 2020 ...
Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators Redazione 2 Luglio 2020 ...
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial Redazione 18 Giugno 2020 ...
